rs368974927
Positions:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2
The NM_005982.4(SIX1):c.746C>T(p.Pro249Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000108 in 1,613,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000092 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00011 ( 0 hom. )
Consequence
SIX1
NM_005982.4 missense
NM_005982.4 missense
Scores
1
8
10
Clinical Significance
Conservation
PhyloP100: 4.23
Genes affected
SIX1 (HGNC:10887): (SIX homeobox 1) The protein encoded by this gene is a homeobox protein that is similar to the Drosophila 'sine oculis' gene product. This gene is found in a cluster of related genes on chromosome 14 and is thought to be involved in limb development. Defects in this gene are a cause of autosomal dominant deafness type 23 (DFNA23) and branchiootic syndrome type 3 (BOS3). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PM1
In a chain Homeobox protein SIX1 (size 283) in uniprot entity SIX1_HUMAN there are 18 pathogenic changes around while only 5 benign (78%) in NM_005982.4
BP4
Computational evidence support a benign effect (MetaRNN=0.027870625).
BS2
High AC in GnomAd4 at 14 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIX1 | NM_005982.4 | c.746C>T | p.Pro249Leu | missense_variant | 2/2 | ENST00000645694.3 | NP_005973.1 | |
SIX1 | XM_017021602.3 | c.*165C>T | 3_prime_UTR_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIX1 | ENST00000645694.3 | c.746C>T | p.Pro249Leu | missense_variant | 2/2 | NM_005982.4 | ENSP00000494686.1 | |||
SIX1 | ENST00000554986.2 | c.227C>T | p.Pro76Leu | missense_variant | 2/2 | 3 | ENSP00000452700.2 | |||
SIX1 | ENST00000553535.2 | n.434C>T | non_coding_transcript_exon_variant | 3/3 | 3 | |||||
SIX1 | ENST00000555955.3 | n.1383C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152014Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
14
AN:
152014
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000159 AC: 40AN: 251256Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135820
GnomAD3 exomes
AF:
AC:
40
AN:
251256
Hom.:
AF XY:
AC XY:
24
AN XY:
135820
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000109 AC: 160AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.000105 AC XY: 76AN XY: 727244
GnomAD4 exome
AF:
AC:
160
AN:
1461886
Hom.:
Cov.:
32
AF XY:
AC XY:
76
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152014Hom.: 0 Cov.: 30 AF XY: 0.0000673 AC XY: 5AN XY: 74248
GnomAD4 genome
AF:
AC:
14
AN:
152014
Hom.:
Cov.:
30
AF XY:
AC XY:
5
AN XY:
74248
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
8
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Autosomal dominant nonsyndromic hearing loss 23 Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Pathogenic, criteria provided, single submitter | research | Laboratory of Prof. Karen Avraham, Tel Aviv University | Jan 01, 2025 | The c.746C>T:p.(Pro249Leu) is classified pathogenic by Deafness Variation Database based on PMID:21280147, where the first hearing impaired individual was reported. A second affected individual was reported to ClinVar by GeneDx (SCV001786287.1) as likely benign even though it was detected in an affected person. We detected this variant in three additional hearing impaired individuals in a WES study where no other candidates were found. All together, there are 5 affected individuals documented that do not have any other candidates identified in WES, supporting pathogenicity of the variant. This variant is common among Ashkenazi Jews (0.3%) but very rare in other population, suggesting a founder effect in the Ashkenazi population. - |
Branchiootic syndrome 3;C1854594:Autosomal dominant nonsyndromic hearing loss 23 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 30, 2023 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 15, 2020 | This variant is associated with the following publications: (PMID: 21280147) - |
SIX1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 21, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Branchiootic syndrome 3 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Uncertain
D;T;D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;L
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;.
REVEL
Uncertain
Sift
Uncertain
D;.;.
Sift4G
Benign
T;D;.
Polyphen
B;.;B
Vest4
MutPred
Loss of glycosylation at P249 (P = 0.0548);.;Loss of glycosylation at P249 (P = 0.0548);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at